Polyrizon (NASDAQ:PLRZ) Shares Cross Above 50-Day Moving Average – Should You Sell?

Polyrizon Ltd. (NASDAQ:PLRZ – Get Free Report) shares crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $10.55 and traded as high as $10.86. Polyrizon shares last traded at $10.75, with a volume of 45,946 shares changing hands.

Wall Street Analysts Forecast Growth

PLRZ has been the subject of a number of research analyst reports. Wall Street Zen lowered Polyrizon from a “hold” rating to a “sell” rating in a research report on Saturday, September 12th. Weiss Ratings downgraded Polyrizon from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, October 8th. One research analyst has rated the stock with a Sell rating. According to MarketBeat, the company has a consensus rating of “Sell”.

Read Our Latest Stock Analysis on PLRZ

Polyrizon Trading Up 19.4%

The company has a fifty day moving average price of $10.55 and a 200-day moving average price of $12.62.

Polyrizon (NASDAQ:PLRZ – Get Free Report) last posted its earnings results on Monday, September 28th. The company reported ($0.40) EPS for the quarter.

About Polyrizon

(Get Free Report)

Polyrizon Ltd. is a biotechnology company focused on developing nasal gels and other intranasal products designed to help protect against airborne allergens, pathogens and pollutants. Its proprietary hydrogel technology is intended to form a physical barrier within the nasal cavity, potentially limiting contact between inhaled particles and nasal tissue.

The company’s development programs are aimed at applications such as allergic rhinitis and the prevention or reduction of exposure to respiratory viruses and other airborne irritants.

Featured Stories

Receive News & Ratings for Polyrizon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polyrizon and related companies with MarketBeat.com's FREE daily email newsletter.